Press "Enter" to skip to content

Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site – FiercePharma

admin 0

Dendreon commits to prostate cancer vaccine Provenge with new lease for manufacturing site  FiercePharma

Dendreon, which last summer changed ownership for a third time in as many years, signaled its faith in prostate drug Provenge by signing a lease extension for …

“prostate cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *